Manufacture

Many drug developers are going ‘full steam ahead’ with personalized medicine strategies.

The rise of drug resistance has left us facing a future with few effective antibiotics. Do the next-generation antibiotics in the pipeline offer hope?

Sitting Down With… Nick Haggar, Head of Western Europe, Middle East & Africa, Sandoz, and President of the European Generic Medicines Association (EGA).

The US is finally introducing regulation on drug serialization and traceability, but gaps remain that could leave patients vulnerable.

Mysterious cyber attackers are hitting pharma manufacturing systems

“Welcome to Big Pharma, where you can make a fortune and still maintain a healthy conscience. Or can you?”

We speak to Derek Gatherer from the Division of Biomedical and Life Sciences at Lancaster University, UK, to get an overview of the Ebola outbreak.

Manufacturing stem cells for use in research is one thing; doing it on a commercial scale is an entirely different ballgame.

Maximizing operational excellence – what have we learned and where do we go next?

Today’s pharmaceutical manufacturing operations capture huge amounts of data. Unfortunately, in many cases the data pass by without actual context.